CompletedNCT05569733
Simultaneous Fluorodeoxyglucose Positron Emission Tomography (PET) and Magnetic Resonance (MR) in Visual Snow Syndrome
Studying Visual snow syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Principal Investigator
- Koen Van Laere, MD PhDHead Nuclear Medicine, University Hospitals Leuven
- Intervention
- simultaneous fluor-18 fluorodeoxyglucose (FDG) positron emission tomography with magnetic resonance imaging (PET/MRI)(diagnostic_test)
- Enrollment
- 22 target
- Eligibility
- 18-85 years · All sexes
- Timeline
- 2017 – 2022
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05569733 on ClinicalTrials.govOther trials for Visual snow syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07110493Study of Visual Perception Phenomena: Phosphene Mapping Induced by TMS and Its Relationship With Eye MovementsSkolkovo Institute of Science and Technology
- RECRUITINGNANCT06961864Investigating Brain Function in People With and Without Visual Snow Syndrome Using Adaptation to Visual StimuliUniversity of Minnesota